These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

165 related items for PubMed ID: 14608242

  • 1. Economic impact of olanzapine plus fluoxetine combination therapy among patients treated for depression: a pilot study.
    Corey-Lisle PK, Birnbaum H, Greenberg P, Marynchenko M, Dube S.
    Psychopharmacol Bull; 2003; 37(3):90-8. PubMed ID: 14608242
    [Abstract] [Full Text] [Related]

  • 2. A randomized, double-blind comparison of olanzapine/fluoxetine combination, olanzapine, and fluoxetine in treatment-resistant major depressive disorder.
    Thase ME, Corya SA, Osuntokun O, Case M, Henley DB, Sanger TM, Watson SB, Dubé S.
    J Clin Psychiatry; 2007 Feb; 68(2):224-36. PubMed ID: 17335320
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Olanzapine/fluoxetine combination for treatment-resistant depression: a controlled study of SSRI and nortriptyline resistance.
    Shelton RC, Williamson DJ, Corya SA, Sanger TM, Van Campen LE, Case M, Briggs SD, Tollefson GD.
    J Clin Psychiatry; 2005 Oct; 66(10):1289-97. PubMed ID: 16259543
    [Abstract] [Full Text] [Related]

  • 5. Long-term weight gain in patients treated with open-label olanzapine in combination with fluoxetine for major depressive disorder.
    Andersen SW, Clemow DB, Corya SA.
    J Clin Psychiatry; 2005 Nov; 66(11):1468-76. PubMed ID: 16420086
    [Abstract] [Full Text] [Related]

  • 6. A preliminary, randomized trial of fluoxetine, olanzapine, and the olanzapine-fluoxetine combination in women with borderline personality disorder.
    Zanarini MC, Frankenburg FR, Parachini EA.
    J Clin Psychiatry; 2004 Jul; 65(7):903-7. PubMed ID: 15291677
    [Abstract] [Full Text] [Related]

  • 7. Olanzapine/fluoxetine: a review of its use in patients with treatment-resistant major depressive disorder.
    Croxtall JD, Scott LJ.
    CNS Drugs; 2010 Mar; 24(3):245-62. PubMed ID: 20155998
    [Abstract] [Full Text] [Related]

  • 8. Olanzapine/fluoxetine combination for the treatment of mixed depression in bipolar I disorder: a post hoc analysis.
    Benazzi F, Berk M, Frye MA, Wang W, Barraco A, Tohen M.
    J Clin Psychiatry; 2009 Oct; 70(10):1424-31. PubMed ID: 19906346
    [Abstract] [Full Text] [Related]

  • 9. Effects of olanzapine alone and olanzapine/fluoxetine combination on health-related quality of life in patients with bipolar depression: secondary analyses of a double-blind, placebo-controlled, randomized clinical trial.
    Shi L, Namjoshi MA, Swindle R, Yu X, Risser R, Baker RW, Tohen M.
    Clin Ther; 2004 Jan; 26(1):125-34. PubMed ID: 14996525
    [Abstract] [Full Text] [Related]

  • 10. Olanzapine/fluoxetine combination in patients with treatment-resistant depression: rapid onset of therapeutic response and its predictive value for subsequent overall response in a pooled analysis of 5 studies.
    Tohen M, Case M, Trivedi MH, Thase ME, Burke SJ, Durell TM.
    J Clin Psychiatry; 2010 Apr; 71(4):451-62. PubMed ID: 20361905
    [Abstract] [Full Text] [Related]

  • 11. An integrated analysis of olanzapine/fluoxetine combination in clinical trials of treatment-resistant depression.
    Trivedi MH, Thase ME, Osuntokun O, Henley DB, Case M, Watson SB, Campbell GM, Corya SA.
    J Clin Psychiatry; 2009 Mar; 70(3):387-96. PubMed ID: 19284928
    [Abstract] [Full Text] [Related]

  • 12. A novel augmentation strategy for treating resistant major depression.
    Shelton RC, Tollefson GD, Tohen M, Stahl S, Gannon KS, Jacobs TG, Buras WR, Bymaster FP, Zhang W, Spencer KA, Feldman PD, Meltzer HY.
    Am J Psychiatry; 2001 Jan; 158(1):131-4. PubMed ID: 11136647
    [Abstract] [Full Text] [Related]

  • 13. Cost-effectiveness of adjunctive therapy with atypical antipsychotics for acute treatment of major depressive disorder.
    Taneja C, Papakostas GI, Jing Y, Baker RA, Forbes RA, Oster G.
    Ann Pharmacother; 2012 May; 46(5):642-9. PubMed ID: 22550279
    [Abstract] [Full Text] [Related]

  • 14. A 24-week open-label extension study of olanzapine-fluoxetine combination and olanzapine monotherapy in the treatment of bipolar depression.
    Corya SA, Perlis RH, Keck PE, Lin DY, Case MG, Williamson DJ, Tohen MF.
    J Clin Psychiatry; 2006 May; 67(5):798-806. PubMed ID: 16841630
    [Abstract] [Full Text] [Related]

  • 15. Effectiveness and cost-effectiveness of antidepressant treatment in primary health care: a six-month randomised study comparing fluoxetine to imipramine.
    Serrano-Blanco A, Gabarron E, Garcia-Bayo I, Soler-Vila M, Caramés E, Peñarrubia-Maria MT, Pinto-Meza A, Haro JM, Depressió en Atenció Primària de Gavà Group (D. A. P. G. A.).
    J Affect Disord; 2006 Apr; 91(2-3):153-63. PubMed ID: 16458976
    [Abstract] [Full Text] [Related]

  • 16. Efficacy and safety of olanzapine/fluoxetine combination vs fluoxetine monotherapy following successful combination therapy of treatment-resistant major depressive disorder.
    Brunner E, Tohen M, Osuntokun O, Landry J, Thase ME.
    Neuropsychopharmacology; 2014 Oct; 39(11):2549-59. PubMed ID: 24801768
    [Abstract] [Full Text] [Related]

  • 17. Efficacy, safety and tolerability of Symbyax for acute-phase management of treatment-resistant depression.
    Bobo WV, Shelton RC.
    Expert Rev Neurother; 2010 May; 10(5):651-70. PubMed ID: 20420487
    [Abstract] [Full Text] [Related]

  • 18. Influence of fluoxetine on olanzapine pharmacokinetics.
    Gossen D, de Suray JM, Vandenhende F, Onkelinx C, Gangji D.
    AAPS PharmSci; 2002 May; 4(2):E11. PubMed ID: 12102620
    [Abstract] [Full Text] [Related]

  • 19. A double-blind, randomized study of olanzapine and olanzapine/fluoxetine combination for major depression with psychotic features.
    Rothschild AJ, Williamson DJ, Tohen MF, Schatzberg A, Andersen SW, Van Campen LE, Sanger TM, Tollefson GD.
    J Clin Psychopharmacol; 2004 Aug; 24(4):365-73. PubMed ID: 15232326
    [Abstract] [Full Text] [Related]

  • 20. An open study of olanzapine and fluoxetine for psychotic major depressive disorder: interim analyses.
    Matthews JD, Bottonari KA, Polania LM, Mischoulon D, Dording CM, Irvin R, Fava M.
    J Clin Psychiatry; 2002 Dec; 63(12):1164-70. PubMed ID: 12523877
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.